Form 4 Filing for CervoMed Inc. - Insider Transaction

Jane H. Hollingsworth, a director at CervoMed Inc. (CRVO), was granted an option to purchase 8,150 shares of common stock on June 8, 2026. This grant, made under the 2025 Equity Incentive Plan, is part of the non-employee director compensation policy and is in connection with her election to the board at the 2026 Annual Meeting of Stockholders. The option has an exercise price of $2.91 and an expiration date of June 8, 2036. The underlying shares will vest monthly over one year, starting June 30, 2026, contingent upon continued service. This transaction is reported on Form 4.